Fortem Financial Group LLC Acquires 115 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Fortem Financial Group LLC grew its stake in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 2.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,263 shares of the company’s stock after purchasing an additional 115 shares during the quarter. Fortem Financial Group LLC’s holdings in HCA Healthcare were worth $1,280,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of HCA. Benjamin F. Edwards & Company Inc. purchased a new position in shares of HCA Healthcare in the 2nd quarter valued at approximately $33,000. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare in the 3rd quarter worth about $39,000. Canoe Financial LP bought a new stake in HCA Healthcare during the third quarter worth about $41,000. Capital Performance Advisors LLP bought a new position in HCA Healthcare during the 3rd quarter valued at approximately $41,000. Finally, Northwest Investment Counselors LLC purchased a new stake in shares of HCA Healthcare in the third quarter worth $44,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

HCA has been the topic of several recent analyst reports. StockNews.com downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Truist Financial reduced their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $380.00 price objective on shares of HCA Healthcare in a report on Tuesday, December 17th. Finally, TD Cowen reduced their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research note on Monday, October 28th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $388.60.

Get Our Latest Research Report on HCA

Insider Buying and Selling at HCA Healthcare

In related news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. This represents a 29.76 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

HCA Healthcare Price Performance

Shares of HCA traded down $0.09 during midday trading on Monday, hitting $296.61. 854,034 shares of the company traded hands, compared to its average volume of 1,008,546. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The stock has a market cap of $75.13 billion, a price-to-earnings ratio of 13.32, a PEG ratio of 1.21 and a beta of 1.64. HCA Healthcare, Inc. has a 52 week low of $276.50 and a 52 week high of $417.14. The firm has a 50 day moving average of $326.93 and a 200-day moving average of $354.99.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.89%. The ex-dividend date was Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Read More

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.